Conference Report: OFCON 2024-25
The Annual Conference of Oncology Forum, OFCON 2024-25, was a landmark gathering of oncology professionals, held to discuss the latest
advancements, innovative practices, and multidisciplinary approaches to cancer care. The event was skilfully organized by Dr. S.V.S. Deo,
Dr. K. Geeta, and Dr. Raghu Ram from Indraprastha Apollo Hospital, whose efforts ensured a dynamic and impactful experience for all attendees.
The program featured a diverse array of sessions covering critical aspects of oncology:
Sessions provided a deep dive into precision oncology, highlighting advancements in personalized treatment and integration of biomarkers.
Panel discussions engaged experts in debating the challenges of immunotherapy, emerging trends in radiation oncology, and developments in diagnostic
and medical oncology.
Sessions explored site-specific cancers, with updates on head and neck, breast, and gynaecologic oncology, emphasizing multidisciplinary strategies.
A special highlight was the felicitation ceremony, honouring three stalwarts for their monumental contributions to oncology:
Dr. Shyam Agarwal (Medical Oncology):
For his leadership in advancing systemic therapies.
Dr. Shelly Hukku (Radiation Oncology):
For his impactful and enterprising work in radiotherapy techniques.
Dr. Anurag Mehta (Oncopathology):
For his excellence in oncologic pathology and diagnostics.
The conference was well attended by 250 doctors and witnessed great enthusiasm from budding oncologists through poster and oral presentations. In all 18 posters and 14 abstracts were presented by our young oncologists.
Winners of OFCON 2024-25 Abstracts are
Bhavya Mishra:
drbhavyamishra08@gmail.com
8427902210
L1 MANDIBLE RECONSTRUCTION GUIDE: ENHANCING PRECISION IN SURGICAL RESTORATION
Gurasis Singh:
gurasis13@gmail.com
8437048620
CONTRAST-ENHANCED MAMMOGRAPHY IN DENSE BREASTS- A PROSPECTIVE STUDY
Meenu Rani:
drmeenu1990@gmail.com
9466204964
ROLE OF CRS HIPEC IN CARCINOMA OVARY WHERE WE STAND TODAY- WITH OUR EXPERIENCE FROM A TERTIARY REFERRAL ONCOLOGY CENTRE, INDIA
Pooja Agarwal:
pooja.star29agarwal@gmail.com
7008937994
A COMPARATIVE STUDY BETWEEN RECIST 1.1 USING MRI AND PERCIST 1.0 USING PET/CT TO EVALUATE THE RESPONSE IN PATIENTS OF CARCINOMA BREAST RECEIVING NEOADJUVANT CHEMOTHERAPY.
Prachi Agarwal:
prachipath123@gmail.com
8006336230
MOLECULAR CHARACTERISATION OF NON- SMALL CELL LUNG CARCINOMA AND ITS CORRELATION WITH HISTOLOGICAL TYPE AND GRADING - A SINGLE TERTIARY CENTRE STUDY
Yatee Gupta:
yateemth@gmail.com
8447287735
HIGH-PERFORMANCE ANTIMICROBIAL HOSPITAL SUPPLIES TO PREVENT SURGICAL SITE INFECTIONS IN CANCER PATIENTS
Winners of Posters are
Ankur Jain:
8839339456
LIMB PRESERVATION IN A CASE OF GIANT CELL TUMOR OF DISTAL RADIUS
Dhiraj Kumar Singh:
dheerajkumarji@aiims.edu
9718791159
ROLE OF PIH1D1 A COMPONENT OF R2TP COMPLEX IN STABILIZATION OF P53 AND CELL CYCLE REGULATION
Rashmi Gupta:
rashmigupta@aiims.edu
9368230256
EPIGENETIC MODULATION IN DENDRITIC CELL-BASED POTE VACCINATION: A PROMISING STRATEGY FOR ADVANCING OVARIAN CANCER IMMUNOTHERAPY
Rohan Kapoor:
drrohankapoor1@gmail.com
9871616029
RELAPSE PATTERN AND ITS MANAGEMENT OF GALL BLADDER CANCER PATIENTS FOLLOWING CURATIVE RESECTION – AN ANALYSIS OF LONG TERM FOLLOW UP DATA FROM SINGLE CENTRE
Shreya Sardana:
sardanashreya28@gmail.com
9041415561
ANALYTICAL REVIEW OF SURGICAL OUTCOMES OF BREAST ONCOPLASTIC TECHNIQUES AT A TERTIARY CENTRE IN INDIA
Venugopal Ravi:
venugopal.ravi108@gmail.com
7780645113
PERIOPERATIVE MORBIDITY AND LONG-TERM OUTCOMES OF PELVIC EXENTERATION FOR LOCALLY ADVANCED PELVIC MALIGNANCIES - A REPORT FROM A TERTIARY ONCOLOGY CENTRE IN INDIA
Several young achievers were recognized for their innovative research and contributions during various sessions.
The event also marked a significant transition in leadership. During the General Body Meeting (GBM), the outgoing president, Dr. S.V.S. Deo, presided over proceedings and passed the baton to the incoming president, Dr. K. Geeta, along with her newly elected team, who will guide the forum for the next two
years.
The engaging deliberations and collaborative spirit of OFCON 2024-25 left participants inspired to embrace innovation and excellence in cancer care. Congratulations to the organizers for curating such a comprehensive and impactful program!